UNSPSC 51312402: Methapyrilene

This classification denotes a histamine-1 receptor antagonist with the molecular formula C14H19N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A01LX40298, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-2-pyridinyl-n-(2-thienylmethyl)- but generally known as methapyrilene, which bears US NIH Compound Identifier 4098. European Medicines Agency schedules Methapyrilene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08839MIG. The term METHAPYRILENE is an International Non-Proprietary Name.

UNSPSC 51312402 Methapyrilene is a Commodity code, but the recent state and local contract opportunities posted under it do not involve methapyrilene procurement. Instead, the code shows activity in emergency-response pharmaceuticals, over-the-counter products, and direct-to-manufacturer prescription programs. Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries), the Texas Health and Human Services Commission posted an RFI on direct-to-manufacturer prescription fulfillment through its Therapeutic Pharmacy Initiative, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) solicited generic multi-source pharmaceuticals and OTC products through an RFP targeting manufacturers for distribution across multiple state and local government facilities. The issuing bodies span state health and human services agencies, county health departments, and regional cooperative purchasing alliances, indicating that state and local procurement under this code encompasses both emergency-response pharmaceutical products and routine generic drug sourcing for government health programs and facilities.

Geographic activity centers on Florida, Texas, and Minnesota through the most recent opportunities, with MMCAP's solicitation covering multiple participating states including Oregon. Seminole County's IFB (S1070000015802, due March 26, 2026) requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson—with pricing weighted 75 percent on competitiveness, 10 percent on fixed pricing, and remainder on EDI capability and administrative compliance; vendors must maintain $5 million commercial general liability and $2 million professional liability insurance and certify cGMP and Drug Supply Chain Security Act compliance. The Seminole County naloxone procurement (IFB60459723LAS, due July 26, 2023) operated on a fixed-fee basis with two-year initial term and one-year renewal option, requiring E-Verify compliance and potentially funded through FEMA. The Texas RFI represents preliminary market research rather than a competitive bid and does not specify budget or formal award timeline.